Ixaka Company

Ixaka is a private cell and gene therapy company with a focus on the natural power of the body to cure disease.
Technology: CAR-T therapy, Cell-based gene therapy, Neurological Disorders
Industry: Gene Therapy, Private
Headquarters: London, England, United Kingdom
Founded Date: 2015-01-01
Employees Number: 51-100
Investors Number: 2
Total Funding: 72659949
Estimated Revenue: $10M to $50M
Last Funding Date: 2021-01-19
Last Funding Type: Venture - Series Unknown

Visit Website
info@ixaka.com
https://twitter.com/_rexgenero
Register and Claim Ownership